Appili Therapeutics Receives FDA and Health Canada Clearance to Begin Clinical Trials on ATI-1501
Appili Therapeutics Receives FDA and Health Canada Clearance to Begin [...]
Newsletter Sign Up
Recent Posts
- Canada in Science – April 6, 2018
- Sunniva Inc. Closes $27.8 Million Bought Deal Public Offering
- Immunovaccine Announces Closing of CAD$14,375,000 Bought Deal Offering with Over-Allotment Option Exercised in Full
- Canada in Science – March 2, 2018
- Big Pharma’s Drug War: Innovative vs. Generic and Biosimilar Drugs